| Product Code: ETC11489353 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 France Cannabis Pharmaceuticals Market Overview |
3.1 France Country Macro Economic Indicators |
3.2 France Cannabis Pharmaceuticals Market Revenues & Volume, 2021 & 2031F |
3.3 France Cannabis Pharmaceuticals Market - Industry Life Cycle |
3.4 France Cannabis Pharmaceuticals Market - Porter's Five Forces |
3.5 France Cannabis Pharmaceuticals Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 France Cannabis Pharmaceuticals Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 France Cannabis Pharmaceuticals Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 France Cannabis Pharmaceuticals Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.9 France Cannabis Pharmaceuticals Market Revenues & Volume Share, By Benefit, 2021 & 2031F |
4 France Cannabis Pharmaceuticals Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing acceptance of medical cannabis in France |
4.2.2 Growing awareness about the potential health benefits of cannabis pharmaceuticals |
4.2.3 Favorable regulatory environment supporting the use of cannabis for medical purposes |
4.3 Market Restraints |
4.3.1 Strict regulations and limited access to medical cannabis in France |
4.3.2 Stigma associated with cannabis use in the healthcare industry |
5 France Cannabis Pharmaceuticals Market Trends |
6 France Cannabis Pharmaceuticals Market, By Types |
6.1 France Cannabis Pharmaceuticals Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 France Cannabis Pharmaceuticals Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 France Cannabis Pharmaceuticals Market Revenues & Volume, By Capsules, 2021 - 2031F |
6.1.4 France Cannabis Pharmaceuticals Market Revenues & Volume, By Oils, 2021 - 2031F |
6.1.5 France Cannabis Pharmaceuticals Market Revenues & Volume, By Topicals, 2021 - 2031F |
6.2 France Cannabis Pharmaceuticals Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 France Cannabis Pharmaceuticals Market Revenues & Volume, By Pain Management, 2021 - 2031F |
6.2.3 France Cannabis Pharmaceuticals Market Revenues & Volume, By Anxiety Relief, 2021 - 2031F |
6.2.4 France Cannabis Pharmaceuticals Market Revenues & Volume, By Skin Conditions, 2021 - 2031F |
6.3 France Cannabis Pharmaceuticals Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 France Cannabis Pharmaceuticals Market Revenues & Volume, By Patients, 2021 - 2031F |
6.3.3 France Cannabis Pharmaceuticals Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.4 France Cannabis Pharmaceuticals Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4 France Cannabis Pharmaceuticals Market, By Source |
6.4.1 Overview and Analysis |
6.4.2 France Cannabis Pharmaceuticals Market Revenues & Volume, By Cannabis-Based, 2021 - 2031F |
6.4.3 France Cannabis Pharmaceuticals Market Revenues & Volume, By Hemp-Based, 2021 - 2031F |
6.4.4 France Cannabis Pharmaceuticals Market Revenues & Volume, By Plant-Based, 2021 - 2031F |
6.5 France Cannabis Pharmaceuticals Market, By Benefit |
6.5.1 Overview and Analysis |
6.5.2 France Cannabis Pharmaceuticals Market Revenues & Volume, By Non-Psychoactive, 2021 - 2031F |
6.5.3 France Cannabis Pharmaceuticals Market Revenues & Volume, By Natural, 2021 - 2031F |
6.5.4 France Cannabis Pharmaceuticals Market Revenues & Volume, By Anti-Inflammatory, 2021 - 2031F |
7 France Cannabis Pharmaceuticals Market Import-Export Trade Statistics |
7.1 France Cannabis Pharmaceuticals Market Export to Major Countries |
7.2 France Cannabis Pharmaceuticals Market Imports from Major Countries |
8 France Cannabis Pharmaceuticals Market Key Performance Indicators |
8.1 Number of licensed healthcare professionals prescribing cannabis pharmaceuticals |
8.2 Research and development investments in cannabis-based pharmaceutical products |
8.3 Patient enrollment in clinical trials for cannabis pharmaceuticals |
9 France Cannabis Pharmaceuticals Market - Opportunity Assessment |
9.1 France Cannabis Pharmaceuticals Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 France Cannabis Pharmaceuticals Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 France Cannabis Pharmaceuticals Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 France Cannabis Pharmaceuticals Market Opportunity Assessment, By Source, 2021 & 2031F |
9.5 France Cannabis Pharmaceuticals Market Opportunity Assessment, By Benefit, 2021 & 2031F |
10 France Cannabis Pharmaceuticals Market - Competitive Landscape |
10.1 France Cannabis Pharmaceuticals Market Revenue Share, By Companies, 2024 |
10.2 France Cannabis Pharmaceuticals Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here